Felix Baker - Net Worth and Insider Trading

Over the past 18 months, Felix Baker made no insider transaction in IGM Biosciences Inc (IGMS). Other recent insider transactions involving IGM Biosciences Inc (IGMS) include a net sale of 11,890 shares made by Lisa Lynn Decker , a net sale of 35,970 shares made by Fred Schwarzer , and a net sale of 15,045 shares made by Bruce Keyt .

In summary, during the past 3 months, insiders sold 5,018 shares of IGM Biosciences Inc (IGMS) in total and bought 0 shares, with a net sale of 5,018 shares. During the past 18 months, 189,975 shares of IGM Biosciences Inc (IGMS) were sold and 1,018,433 shares were bought by its insiders, resulting in a net purchase of 828,458 shares.

IGM Biosciences Inc (IGMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Incyte Corp (INCY). Other recent insider transactions involving Incyte Corp (INCY) include a net sale of 32,298 shares made by Barry P Flannelly , a net sale of 4,624 shares made by Thomas Tray , and a net sale of 40,484 shares made by Steven H Stein .

In summary, during the past 3 months, insiders sold 11,023 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 11,023 shares. During the past 18 months, 116,576 shares of Incyte Corp (INCY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,576 shares.

Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Kodiak Sciences Inc (KOD). Other recent insider transactions involving Kodiak Sciences Inc (KOD) include a net sale of 4,432 shares made by John A. Borgeson ,

In summary, during the past 3 months, insiders sold 0 shares of Kodiak Sciences Inc (KOD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,432 shares of Kodiak Sciences Inc (KOD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,432 shares.

Kodiak Sciences Inc (KOD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Prelude Therapeutics Inc (PRLD). Other recent insider transactions involving Prelude Therapeutics Inc (PRLD) include a net purchase of 106,888 shares made by Krishna Vaddi , and a net purchase of 25,000 shares made by Bryant David Lim .

In summary, during the past 3 months, insiders sold 0 shares of Prelude Therapeutics Inc (PRLD) in total and bought 131,888 shares, with a net purchase of 131,888 shares. During the past 18 months, 0 shares of Prelude Therapeutics Inc (PRLD) were sold and 131,888 shares were bought by its insiders, resulting in a net purchase of 131,888 shares.

Prelude Therapeutics Inc (PRLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 150,848 shares made by John Paolini , a net sale of 92,017 shares made by Eben Tessari , and a net sale of 309,021 shares made by Sanj K Patel .

In summary, during the past 3 months, insiders sold 198,169 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 198,169 shares. During the past 18 months, 720,332 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 720,332 shares.

Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Atreca Inc (BCEL). Other recent insider transactions involving Atreca Inc (BCEL) include a net sale of 34,668 shares made by Tito Serafini , a net sale of 11,137 shares made by Phillips Courtney , and a net sale of 274,739 shares made by Baker Bros. Advisors Lp .

In summary, during the past 3 months, insiders sold 0 shares of Atreca Inc (BCEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 353,058 shares of Atreca Inc (BCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,058 shares.

Atreca Inc (BCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in BeiGene Ltd (BGNE). Other recent insider transactions involving BeiGene Ltd (BGNE) include a net sale of 120,245 shares made by John Oyler , a net sale of 3,156 shares made by Julia Aijun Wang , and a net sale of 15,269 shares made by Xiaobin Wu .

In summary, during the past 3 months, insiders sold 18,992,005 shares of BeiGene Ltd (BGNE) in total and bought 0 shares, with a net sale of 18,992,005 shares. During the past 18 months, 20,220,106 shares of BeiGene Ltd (BGNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 20,220,106 shares.

BeiGene Ltd (BGNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 319,936 shares made by Stephen Davis , a net sale of 48,500 shares made by Mark C. Schneyer , and a net sale of 37,363 shares made by Brendan Teehan .

In summary, during the past 3 months, insiders sold 24,661 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 24,661 shares. During the past 18 months, 436,406 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 436,406 shares.

ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Seagen Inc (SGEN). Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 19,816 shares made by Vaughn B Himes , a net sale of 1,746 shares made by Charles R Romp , and a net sale of 5,116 shares made by Roger D Dansey .

In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 47,272 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 47,272 shares.

Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Zymeworks Inc (ZYME). Other recent insider transactions involving Zymeworks Inc (ZYME) include a net sale of 6,880 shares made by Christopher Astle , a net sale of 23,904 shares made by Kenneth Galbraith , and a net sale of 9,799 shares made by Paul Andrew Moore .

In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,583 shares of Zymeworks Inc (ZYME) were sold and 0 shares were bought by its insiders, resulting in a net sale of 40,583 shares.

Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp , and a net sale of 1,323 shares made by Sean Michael Smith .

In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 66 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 114,201 shares.

Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Aceragen Inc (ACGN). Other recent insider transactions involving Aceragen Inc (ACGN) include a net sale of 5,818 shares made by Pillar Invest Corp , a net sale of 3,283 shares made by Vincent Milano , and a net sale of 51 shares made by Maxine Gowen .

In summary, during the past 3 months, insiders sold 0 shares of Aceragen Inc (ACGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,152 shares of Aceragen Inc (ACGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,152 shares.

Aceragen Inc (ACGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in HOOKIPA Pharma Inc (HOOK). Other recent insider transactions involving HOOKIPA Pharma Inc (HOOK) include a net purchase of 27,000 shares made by Reinhard Kandera , and a net purchase of 20,000 shares made by Jorn Aldag .

In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HOOKIPA Pharma Inc (HOOK) were sold and 4,700 shares were bought by its insiders, resulting in a net purchase of 4,700 shares.

HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Invitae Corp (NVTAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Invitae Corp (NVTAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Invitae Corp (NVTAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Bellicum Pharmaceuticals Inc (BLCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bellicum Pharmaceuticals Inc (BLCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Bellicum Pharmaceuticals Inc (BLCM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 7,903 shares made by Jamie Christensen , a net sale of 5,907 shares made by Benjamin Hickey , and a net purchase of 2,517,946 shares made by Boxer Capital, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,810 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,514,927 shares.

Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 184,943 shares made by Joseph Shulman , a net sale of 145,755 shares made by Jennifer Chien , and a net sale of 85,162 shares made by Pamela J. Cramer .

In summary, during the past 3 months, insiders sold 89,517 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 89,517 shares. During the past 18 months, 672,183 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 672,183 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 2,000 shares made by Nancy J Hutson , a net purchase of 36,300 shares made by Anthony Doyle , and a net purchase of 30,000 shares made by Charles K Gayer .

In summary, during the past 3 months, insiders sold 7,000 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 7,000 shares. During the past 18 months, 26,987 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 156,614 shares.

BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 5,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 7,807 shares made by Laura Sepp-lorenzino .

In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 57,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 57,207 shares.

Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in XOMA Royalty Corp (XOMA). Other recent insider transactions involving XOMA Royalty Corp (XOMA) include a net sale of 18,381 shares made by Owen Hughes , a net sale of 9,775 shares made by Thomas M. Burns , and a net purchase of 1,750 shares made by Bradley Sitko .

In summary, during the past 3 months, insiders sold 31,656 shares of XOMA Royalty Corp (XOMA) in total and bought 0 shares, with a net sale of 31,656 shares. During the past 18 months, 31,656 shares of XOMA Royalty Corp (XOMA) were sold and 5,250 shares were bought by its insiders, resulting in a net sale of 26,406 shares.

XOMA Royalty Corp (XOMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .

In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.

Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of XOMA Royalty Corp (XOMAO.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Royalty Corp (XOMAO.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XOMA Royalty Corp (XOMAO.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Talis Biomedical Corp (TLIS). Other recent insider transactions involving Talis Biomedical Corp (TLIS) include a net purchase of 45,133 shares made by Braden Michael Leonard ,

In summary, during the past 3 months, insiders sold 0 shares of Talis Biomedical Corp (TLIS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Talis Biomedical Corp (TLIS) were sold and 45,133 shares were bought by its insiders, resulting in a net purchase of 45,133 shares.

Talis Biomedical Corp (TLIS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in DBV Technologies SA (DBVT). Other recent insider transactions involving DBV Technologies SA (DBVT) include a net sale of 8,329 shares made by Pharis Mohideen , a net purchase of 17,094 shares made by Daniel Tasse , and a net purchase of 15,000 shares made by Daniel B Soland .

In summary, during the past 3 months, insiders sold 651 shares of DBV Technologies SA (DBVT) in total and bought 0 shares, with a net sale of 651 shares. During the past 18 months, 1,337 shares of DBV Technologies SA (DBVT) were sold and 4,592 shares were bought by its insiders, resulting in a net purchase of 3,255 shares.

DBV Technologies SA (DBVT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Spyre Therapeutics Inc (SYRE). Other recent insider transactions involving Spyre Therapeutics Inc (SYRE) include a net sale of 7,000 shares made by Jeffrey W. Albers , and a net sale of 18,531 shares made by Scott L Burrows .

In summary, during the past 3 months, insiders sold 7,000 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 7,000 shares. During the past 18 months, 25,531 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,531 shares.

Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Entrada Therapeutics Inc (TRDA). Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 12,900 shares made by Dipal Doshi , a net sale of 80,157 shares made by Natarajan Sethuraman , and a net sale of 47,126 shares made by Kory James Wentworth .

In summary, during the past 3 months, insiders sold 142,900 shares of Entrada Therapeutics Inc (TRDA) in total and bought 0 shares, with a net sale of 142,900 shares. During the past 18 months, 297,371 shares of Entrada Therapeutics Inc (TRDA) were sold and 45,368 shares were bought by its insiders, resulting in a net sale of 252,003 shares.

Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in TScan Therapeutics Inc (TCRX). Other recent insider transactions involving TScan Therapeutics Inc (TCRX) include a net purchase of 20,000 shares made by Barbara Klencke , a net purchase of 132,747 shares made by Lynx1 Capital Management Lp , and a net sale of 164,686 shares made by Zoran Zdraveski .

In summary, during the past 3 months, insiders sold 0 shares of TScan Therapeutics Inc (TCRX) in total and bought 132,747 shares, with a net purchase of 132,747 shares. During the past 18 months, 164,686 shares of TScan Therapeutics Inc (TCRX) were sold and 181,894 shares were bought by its insiders, resulting in a net purchase of 17,208 shares.

TScan Therapeutics Inc (TCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Felix Baker made no insider transaction in Madrigal Pharmaceuticals Inc (MDGL). Other recent insider transactions involving Madrigal Pharmaceuticals Inc (MDGL) include a net purchase of 424,685 shares made by Baker Bros. Advisors Lp , a net sale of 12,736 shares made by Robert E. Waltermire , and a net sale of 29,489 shares made by Fred B Craves .

In summary, during the past 3 months, insiders sold 17,688 shares of Madrigal Pharmaceuticals Inc (MDGL) in total and bought 0 shares, with a net sale of 17,688 shares. During the past 18 months, 321,618 shares of Madrigal Pharmaceuticals Inc (MDGL) were sold and 424,685 shares were bought by its insiders, resulting in a net purchase of 103,067 shares.

Madrigal Pharmaceuticals Inc (MDGL)'s detailed insider trading history can be found in Insider Trading Tracker table.